Skip to main content
Log in

Reply to the comments of Dr. Grieve

  • Letters to the editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Pabst G, Jaeger H (1990) Review of methods and criteria for the evaluation of bioquivalence studies. Eur J Clin Pharmacol 38: 5–10

    Google Scholar 

  2. Selwyn MR, Hall NR (1984) On Bayesian methods for bioequivalence. Biometrics 40: 1103–1108

    Google Scholar 

  3. Flühler H, Grieve AP, Mandallaz D, Mau J, Moser HA (1983) Bayesian approach to bioquivalence assessment: An example. J Pharmaceut Sci 72: 1178–1181

    Google Scholar 

  4. Anderson S, Hauck WW (1990) Consideration of individual bioequivalence. J Pharmacokin Biopharmaceut 18: 259–273

    Google Scholar 

  5. Steinijans VW, Hauschke D (1990) Update on the statistical analysis of bioequivalence studies. Int J Clin Pharmacol Ther Toxicol 28: 105–110

    Google Scholar 

  6. Hollander M, Wolfe DA (1973) Nonparametric statistical methods. Wiley and Sons, New York

    Google Scholar 

  7. Hauschke D, Steinijans VW, Diletti E (1990) A distribution-free procedure for the statistical analysis of bioequivalence studies. Int J Clin Pharmacol Ther Toxicol 28: 72–78

    Google Scholar 

  8. Koch GG (1972) The use of nonparametric methods in the statistical analysis of the two-period change-over design. Biometrics 28: 577–584

    Google Scholar 

  9. Gardner MJ, Altman DG (1986) Confidence intervals rather than P values: estimation rather than hypothesis testing. Br Med J 292: 746–750

    Google Scholar 

  10. Rodda BE, Davis LD (1980) Determining the probability of an important difference in bioavailability. Clin Pharmacol Ther 28: 247–252

    Google Scholar 

  11. Frick H (1987) On level and power of Anderson and Hauck's procedure for testing equivalence in comparative bioavailability. Commun Statist Theory Meth 16: 2771–2778

    Google Scholar 

  12. Rocke DM (1984) On testing for bioequivalence. Biometrics 40: 225–230

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pabst, G. Reply to the comments of Dr. Grieve. Eur J Clin Pharmacol 40, 202–203 (1991). https://doi.org/10.1007/BF00280081

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00280081

Navigation